{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:57:46Z","timestamp":1779217066925,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,21]]},"DOI":"10.7759\/cureus.105601","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T15:28:31Z","timestamp":1774106911000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Anemia and Acute Kidney Injury After Pegloticase in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency"],"prefix":"10.7759","author":[{"given":"Noor","family":"Zainab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Zahdeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled W","family":"Erekat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle N","family":"Ritota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"El Hajj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiswarya","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umair","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4497","article-title":"Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout","volume":"16","author":"Lipsky PE","year":"2014","unstructured":"Lipsky PE, Calabrese LH, Kavanaugh A, Sundy JS, Wright D, Wolfson M, Becker MA. Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout. Arthritis Res Ther. 2014, 16:R60. 10.1186\/ar4497","journal-title":"Arthritis Res Ther"},{"key":"ref2","unstructured":"Krystexxa (pegloticase) prescribing information. (2022). https.\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/125293s104lbl.pdf."},{"key":"ref3","article-title":"Pegloticase","author":"Padda IS","year":"2024","unstructured":"Padda IS, Bhatt R, Patel P. Pegloticase. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"Luzzatto L","year":"2020","unstructured":"Luzzatto L, Ally M, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Blood. 2020, 136:1225-40. 10.1182\/blood.2019000944","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60073-2","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"371","author":"Cappellini MD","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008, 371:64-74. 10.1016\/S0140-6736(08)60073-2","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000370","article-title":"Hemolytic anemia induced by pegloticase infusion in a patient with G6PD deficiency","volume":"22","author":"Owens RE","year":"2016","unstructured":"Owens RE, Swanson H, Twilla JD. Hemolytic anemia induced by pegloticase infusion in a patient with G6PD deficiency. J Clin Rheumatol. 2016, 22:97-8. 10.1097\/RHU.0000000000000370","journal-title":"J Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu346","article-title":"Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result","volume":"53","author":"Geraldino-Pardilla L","year":"2014","unstructured":"Geraldino-Pardilla L, Sung D, Xu JZ, Shirazi M, Hod EA, Francis RO. Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result. Rheumatology (Oxford). 2014, 53:2310-11. 10.1093\/rheumatology\/keu346","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14740\/jh402w","article-title":"Pegloticase induced hemolytic anemia in a patient with G6PD deficiency","volume":"7","author":"Adashek ML","year":"2018","unstructured":"Adashek ML, Bourji KI. Pegloticase induced hemolytic anemia in a patient with G6PD deficiency. J Hematol. 2018, 7:83-5. 10.14740\/jh402w","journal-title":"J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000828","article-title":"Pegloticase-associated hemolysis","volume":"26","author":"Minshar MA","year":"2019","unstructured":"Minshar MA, Osman-Malik Y, Bhat ZY. Pegloticase-associated hemolysis. Am J Ther. 2019, 26:e622-4. 10.1097\/MJT.0000000000000828","journal-title":"Am J Ther"},{"key":"ref10","article-title":"Pegloticase therapy and G6PD genotype","author":"Dean L","year":"2020","unstructured":"Dean L, Kane M. Pegloticase therapy and G6PD genotype. Medical Genetics Summaries [Internet]. Pratt VM, Scott SA, Pirmohamed M, et al. (ed): National Center for Biotechnology Information (US), Bethesda (MD); 2020."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0005442022","article-title":"Heme proteins and kidney injury: beyond rhabdomyolysis","volume":"3","author":"Nath KA","year":"2022","unstructured":"Nath KA, Singh RD, Croatt AJ, Adams CM. Heme proteins and kidney injury: beyond rhabdomyolysis. Kidney360. 2022, 3:1969-79. 10.34067\/KID.0005442022","journal-title":"Kidney360"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/470451-severe-anemia-and-acute-kidney-injury-after-pegloticase-in-a-patient-with-glucose-6-phosphate-dehydrogenase-deficiency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T15:28:32Z","timestamp":1774106912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/470451-severe-anemia-and-acute-kidney-injury-after-pegloticase-in-a-patient-with-glucose-6-phosphate-dehydrogenase-deficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.105601","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,21]]}}}